breast milk from the Human Milk Bank, Christchurch Women's Hospital were homogenised, and energy and macronutrient content were analysed using a Miris Human Milk Analyser. Mixed effects regression models investigated the impact of three maternal characteristics on milk composition (gestational age and sex of the donor's infant and lactation weeks of the donor or alternatively whether milk was term or preterm).
Results: After Holder pasteurisation, there was a small (≤3%) but significant reduction (all p ≤ 0.001) in the energy, fat and carbohydrate concentrations of milk. The energy and macronutrient content of pasteurised donor breast milk was highly variable. The protein concentration of pasteurised donor breast milk was significantly lower in term breast milk compared to preterm (−0.20 g/100 mL, p < 0.001).
Conclusions: The variance in donor breast milk indicates the importance of determining the nutrient composition of donated milk, for the benefit of improving individualised fortification procedures. Background: Meconium-stained amniotic fluid (MSAF) is a common occurrence and often considered an indicator of poor foetal wellbeing. Contemporary research comparing the neonatal outcomes of those with MSAF compared to clear amniotic fluid remains equivocal. Additionally, research has predominantly been conducted in countries that differ to Australia on demographic characteristics, antenatal, intrapartum and neonatal management. Therefore, the aim of this study is to identify important associations between MSAF and adverse neonatal outcomes at Northern Health, Melbourne over a five-year period.
MECONIUM-STAINED

Methods:
We conducted a retrospective cross-sectional study of all deliveries at Northern Health, Melbourne between 1 January 2013 to 31 December 2017. Exclusion criteria included: twin pregnancy, prematurity, non-cephalic presentation, known foetal chromosomal or structural abnormalities, preeclampsia and suspected chorioamnionitis. Data on participant demographic characteristics, obstetric measures and neonatal outcomes were obtained from electronic health records.
Results: There was a total of 17 076 deliveries at Northern Health. 3925 participants were excluded. The overall incidence of MSAF was 16.4% (n = 2157). Using multivariate logistic regression, MSAF was independently associated with a 5-min Apgar score < 7 (OR 2.26, 95% CI: 1.59-3.21), neonatal sepsis (OR 1.56, 95% CI: 1.28-1.89) and respiratory distress (OR 2.18, 95% CI: 1.58-3.02).
Conclusion: MSAF is independently associated with adverse neonatal outcomes, including a 5-min Apgar score < 7, neonatal sepsis and respiratory distress, even with the modern advancements in obstetric and neonatal care. Consequently, closer surveillance during labour, delivery and the immediate neonatal period are necessary. Background: It is well established that prenatal mortality and morbidity are increased in pregnancies affected by diabetes compared to pregnancies not affected by diabetes. The risk of congenital heart disease is also significantly increased and contributes to the mortality and morbidity rates. There also risks of fetal macrosomia and unexplained sudden intrauterine death. NICE guidelines recommend monitoring pregnancies affected by diabetes with ultrasound assessment at 20 weeks gestation, especially to assess for structural cardiac anomalies, and at 28, 32 and 36 weeks gestation for fetal growth and amniotic fluid volume assessment. While polyhydramnios has been shown to occur more frequently with poor glycemic control this does not seem to be related to adverse pregnancy outcome. Detection of macrosomia by ultrasound in the third trimester is also suboptimal. The evidence for the use of fetoplacental Dopplers in diabetic pregnancies is also lacking. It is known that maternal hyperglycemia is a risk factor for both structural and functional fetal cardiac abnormalities and it may be that assessment of cardiac function will provide a better snapshot of fetal wellbeing.
DIABETES IN PREGNANCY: IS THERE A BETTER WAY TO ASSESS FETAL WELLBEING?
Methods: This presentation will cover various techniques of fetal cardiac function using 2D, M-mode and PW ultrasound as well as newer techniques of Tissue Doppler (TDI) and Strain imaging.
Results: Data on longitudinal assessment of fetal cardiac function from pregnancies complicated by diabetes mellitus will be presented.
Conclusions: Assessment of cardiac function may provide a better way to monitor fetal wellbeing in pregnancies complicated by diabetes.
